Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia

AIM: To evaluate addition of boceprevir to peginterferon/ribavirin (PR) in Russian patients with chronic hepatitis C virus (HCV). METHODS: Treatment-naive (TN) and treatment-experienced (TE) patients (who had failed prior treatment with PR for ≥ 12 wk) with chronic HCV genotype 1 infection were enro...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:World J Hepatol
मुख्य लेखकों: Isakov, Vasily, Nikitin, Igor, Chulanov, Vladimir, Ogurtsov, Pavel, Lukyanova, Ekaterina, Long, Jianmin, Wahl, Janice, Helmond, Frans A
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Baishideng Publishing Group Inc 2016
विषय:
Randomized Controlled Trial
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4766261/
https://ncbi.nlm.nih.gov/pubmed/26962399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v8.i6.331
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन